Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Puerto Rican children with cancer often experience symptoms like irritability, nausea, and hair loss, and need better education and continuous symptom management.

Lupus patients' body image issues significantly affect their mental health and need more support.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

Older patients with Cushing's syndrome often have different symptoms and treatment outcomes compared to younger patients.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Laser treatment and deroofing are effective options for hidradenitis suppurativa.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

The mouse models are effective for testing new hair loss treatments.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Antibody treatments show promise for hair loss but need more research.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.

Latanoprost is more effective than minoxidil for treating alopecia areata.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Spironolactone is effective and safe for treating hair loss, excessive hair growth, and acne.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

FDA-cleared devices often fail to produce high-quality platelet-rich plasma consistently.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

The symposium concluded that understanding the molecular mechanisms of skin aging could lead to better clinical practices and treatments.

Low-dose dutasteride effectively and safely promotes hair growth in men with androgenetic alopecia.

The 1565 nm non-ablative fractional laser is more effective and satisfying than 5% minoxidil for treating hair loss.

Clascoterone may be an effective topical treatment for hair loss.

Standardized PRP therapy can improve treatment for hair loss.

Children with darker skin tones can have specific skin conditions that need tailored treatments.

5-alpha reductase inhibitors are generally safe but can cause sexual side effects and require patient education on risks.